Sweden and China make new Patent Prosecution Highway agreement

In Insights, Uncategorized

9 October, 2014

Effective 1 July 2014 the PRV (Sweden) and the SIPO (China) started a new PPH-agreement thus offering especially our Swedish clients a new way of speeding up examination of patent applications in China by requesting that the SIPO use the search and examination results of the PRV in treating an analogous patent application. The PPH agreement between the PRV and the SIPO applies to both national and PCT work products.

Meanwhile, the SIPO has been even more active by also signing PPH agreements with the patent offices of the UK and Iceland.

The PPH-network keeps expanding

Furthermore, the PPH-network continuously keeps expanding as new intellectual property offices take interest in making PPH-agreements. The most recent additions count the Intellectual Property Offices of countries such as Indonesia, Poland and Nicaragua as well as the Eurasian patent office (EAPO). In total the PPH network now counts the intellectual property offices of 32 countries and regions.

The complete overview of existing and working PPH agreements at the time of writing can be seen on the graphic below, courtesy of the PPH web-page compiled by the Japanese Patent Office, JPO:

PPHJuly2014

Troels Peter Rørdam, European Patent Attorney & Certified Danish Patent Agent

Link to the PRV-SIPO agreement at the PRV.

You may also be interested in:

Navigating Meta’s shifted Moderation Model: What brand owners should prepare for

Meta is shifting away from third-party fact-checking and adopting the Community Notes Model, first introduced by X (formerly Twitter) under Elon Musk’s

Read more...

Companies with IP generate at least 23.8% more revenue according to latest EU report

The report ‘The Intellectual Property Rights and Firm Performance in the European Union’ was published last month and analyses

Read more...

European Commission reports show misuse of divisionals can in itself contravene EU law

In November last year, I was interviewed about the European Commission’s €462.6 million fine against pharmaceutical giant Teva and

Read more...

Mobile Sliding Menu